The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key regions has introduced significant volatility. Investors are now grappling with the consequences of riv